FDA approves fall Covid shots, but with new restrictions

The Food and Drug Administration approved the next round of Covid shots for the fall — but only for a smaller, high-risk group of people, Health and Human Services Secretary Robert F. Kennedy Jr.

The Food and Drug Administration approved the next round of Covid shots for the fall — but only for a smaller, high-risk group of people, Health and Human Services Secretary Robert F. Kennedy Jr. said Wednesday.

The updated Covid shots are approved for adults 65 and older as well as for kids and adults with at least one medical condition that puts them at risk of severe illness.

Kennedy announced the approval in a post on X.

“FDA has now issued marketing authorization for those at higher risk: Moderna (6+ months), Pfizer (5+), and Novavax (12+),” Kennedy wrote. “These vaccines are available for all patients who choose them after consulting with their doctors.”

Kennedy also said that emergency use authorizations for the vaccines had been rescinded.